Brief: Idorsia’S Jeraygo (Aprocitentan) Approved In Canada For The Treatment Of Resistant Hypertension
05/01/2026 06:00
Jan 5 (Reuters) - IDORSIA LTD IDIA.S: JERAYGO (APROCITENTAN) APPROVED IN CANADA FOR THE TREATMENT OF RESISTANT HYPERTENSION Source text: ID:nGNE5ckxFw Further company coverage: IDIA.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))